BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 16637867)

  • 1. Characteristics of HCV positive subjects referring to hospitals in Italy: a multicentre prevalence study on 6,999 cases.
    Stroffolini T; Sagnelli E; Mariano A; Craxí A; Almasio P;
    J Viral Hepat; 2006 May; 13(5):351-4. PubMed ID: 16637867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HCV infection is a risk factor for gallstone disease in liver cirrhosis: an Italian epidemiological survey.
    Stroffolini T; Sagnelli E; Mele A; Cottone C; Almasio PL;
    J Viral Hepat; 2007 Sep; 14(9):618-23. PubMed ID: 17697013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
    Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
    J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of hepatitis C virus infection in a southern Italian rural region. Clinical aspects and evidence of inapparent parenteral exposure.
    Cecere A; Marotta F; Lucariello A; Tancredi L; Vangieri B; Gattoni A
    Panminerva Med; 2003 Dec; 45(4):253-9. PubMed ID: 15206166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study.
    Gramenzi A; Conti F; Felline F; Cursaro C; Riili A; Salerno M; Gitto S; Micco L; Scuteri A; Andreone P; Bernardi M
    J Viral Hepat; 2010 May; 17(5):360-6. PubMed ID: 19758274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
    Larsen C; Bousquet V; Delarocque-Astagneau E; Pioche C; Roudot-Thoraval F; ; ; Desenclos JC
    J Med Virol; 2010 Oct; 82(10):1647-54. PubMed ID: 20827760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drinking habits and risk of altered liver enzymes in the general population of a rural area in Southern Italy.
    Loguercio C; Federico A; Bianchi C; D'Auria M; Tallarico A; Bianco M; Fiorito R; Del Vecchio Blanco C; Stroffolini T
    Dig Liver Dis; 2007 Aug; 39(8):748-52. PubMed ID: 17604238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of alcohol intake and cofactors on the risk of cirrhosis.
    Stroffolini T; Cotticelli G; Medda E; Niosi M; Del Vecchio-Blanco C; Addolorato G; Petrelli E; Salerno MT; Picardi A; Bernardi M; Almasio P; Bellentani S; Surace LA; Loguercio C
    Liver Int; 2010 Jul; 30(6):867-70. PubMed ID: 20492499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.
    Chakravarti A; Verma V; Jain M; Kar P
    Trop Gastroenterol; 2005; 26(4):183-7. PubMed ID: 16737047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excess mortality of hepatocellular carcinoma and morbidity of liver cirrhosis and hepatitis in HCV-endemic areas in an HBV-endemic country: geographic variations among 502 villages in southern Taiwan.
    Tsai MC; Kee KM; Chen YD; Lin LC; Tsai LS; Chen HH; Lu SN
    J Gastroenterol Hepatol; 2007 Jan; 22(1):92-8. PubMed ID: 17201888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for hepatocellular carcinoma in patients with alcoholic or viral C cirrhosis.
    N'Kontchou G; Paries J; Htar MT; Ganne-Carrie N; Costentin L; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Clin Gastroenterol Hepatol; 2006 Aug; 4(8):1062-8. PubMed ID: 16844421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
    Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reconstructing and predicting the hepatitis C virus epidemic in Greece: increasing trends of cirrhosis and hepatocellular carcinoma despite the decline in incidence of HCV infection.
    Sypsa V; Touloumi G; Tassopoulos NC; Ketikoglou I; Vafiadis I; Hatzis G; Tsantoulas D; Akriviadis E; Delladetsima J; Demonakou M; Hatzakis A
    J Viral Hepat; 2004 Jul; 11(4):366-74. PubMed ID: 15230860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural course of chronic HCV and HBV infection and role of alcohol in the general population: the Dionysos Study.
    Bedogni G; Miglioli L; Masutti F; Ferri S; Castiglione A; Lenzi M; Crocè LS; Granito A; Tiribelli C; Bellentani S
    Am J Gastroenterol; 2008 Sep; 103(9):2248-53. PubMed ID: 18637095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.
    Kayali Z; Tan S; Shinkunas L; Voigt M; LaBrecque DR; Stapleton JT; Brown KE; Schmidt WN
    J Viral Hepat; 2007 Jan; 14(1):11-21. PubMed ID: 17212639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
    Vaiphei K; Pal NS; Arora SK
    Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
    d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
    Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Independent and combined action of hepatitis C virus infection and alcohol consumption on the risk of symptomatic liver cirrhosis.
    Corrao G; Aricò S
    Hepatology; 1998 Apr; 27(4):914-9. PubMed ID: 9537428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type 2 diabetes and hepatocellular carcinoma: A cohort study in high prevalence area of hepatitis virus infection.
    Lai MS; Hsieh MS; Chiu YH; Chen TH
    Hepatology; 2006 Jun; 43(6):1295-302. PubMed ID: 16729295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
    Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
    Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.